Sec

Omicron Scare: Subject Expert Committee To Hold Meeting Tomorrow Over Booster Doses

'Shocking, Terrible': SC Seeks Centre's Response Over Filing Cases Under Scrapped Sec 66A Of IT Act

Bharat Biotech Gets Approval To Start Next Phase Of Clinical Trials Of 'Covaxin' On Children Aged 2-18 Years